Trials / Recruiting
RecruitingNCT06535945
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Albumin administration | when albumin serum concentration is at 30 g/L or below |
Timeline
- Start date
- 2025-03-26
- Primary completion
- 2028-04-26
- Completion
- 2028-04-26
- First posted
- 2024-08-02
- Last updated
- 2025-12-09
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06535945. Inclusion in this directory is not an endorsement.